Medicine
Adenine and Dextrose, unspecified form 0.09 g/3 g per 300 mL injection
Adenine and Dextrose, unspecified form 0.09 g/3 g per 300 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing Storage and handling Storage and handling Store at room…
Key facts
- Active ingredient (INN)
- Adenine and Dextrose, unspecified form
- Brand
- Sold under the generic name
- Strength
- 0.09 g/3 g per 300 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 25 bags of 300 mL
- Manufacturer
- Gvs Tm
- Origin register
- US FDA, United States
- Storage
- Protect from freezing Storage and handling Storage and handling Store at room temperature (25 °C/77 °F). Protect from freezing. Store at room temperature (25 °C/77 °F). Storage and handling
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 September 2025
- Identifiers
- DailyMed set ID 3dfa3397-fc13-4659-e063-6394a90a5abcNDC 87069-462Application BN820915
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 bag in 1 carton / 300 mL in 1 bag | 87069-462-33 | Gvs Tm | 15 September 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Adenine and Dextrose, unspecified form
Clinical summary
Clinical information for Adenine and Dextrose, unspecified form is on its overview page.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Adenine and Dextrose, unspecified formFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
Need Adenine and Dextrose, unspecified form 0.09 g/3 g per 300 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.